2001Ningxia Medical JournalRequires access

Effect of different doses of mannitol in patients with raised intracranial pressure

Chen Zen-ru

Open publisher page 0 citations

Abstract

Objectives To evaluate the effect of different doses of mannitol on the patients of raised intracranial pressure and to observe the relationship between different doses of mannitol and sequent developing acute kidney failure.Methods We have collected 191 cases with raised intracranial pressure(GCS 6~10)divided randomly into three groups receiving the doses of mannitol 0.25g.kg 1 (n=63) 、0.5g.kg 1 (n=65)and 1.0g.kg 1 (n=63)respectively,the various effects and probability of sequent developing acute kidney failure in these three groups have be compared.Results The morbility of acute kidney failure is markedly relative to the doses of mannitol which patients were infused.Otherwise the effect of different doses of mannitol is variant.The effect is better in the mid-dose (0.5g.kg 1 )and the high-dose(1.0g.kg 1 )mannitol groups than in the low-dose group.Conclusions The present result indicates that the benefit effect is better in the mid-dose of mannitol group and the morbidity of acute kidney failure is lower than the high-dose group.

About this research paper

What this paper is about

Objectives To evaluate the effect of different doses of mannitol on the patients of raised intracranial pressure and to observe the relationship between different doses of mannitol and sequent developing acute kidney failure.Methods We have collected 191 cases with raised intracranial pressure(GCS 6~10)divided randomly into three groups receiving the doses of mannitol 0.25g.kg 1 (n=63) 、0.5g.kg 1 (n=65)and 1.0g.kg 1 (n=63)respectively,the various effects and probability of sequent developing acute kidney failure in these three groups have be compared.Results The morbility of acute kidney failure is markedly relative to the doses of mannitol which patients were infused.Otherwise the effect of different doses of mannitol is variant.The effect is better in the mid-dose (0.5g.kg 1 )and the high-dose(1.0g.kg 1 )mannitol groups than in the low-dose group.Conclusions The present result indicates that the benefit effect is better in the mid-dose of mannitol group and the morbidity of acute kidney failure is lower than the high-dose group.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objectives To evaluate the effect of different doses of mannitol on the patients of raised intracranial pressure and to observe the relationship between different doses of mannitol and sequent developing acute kidney failure.Methods We have collected 191 cases with raised intracranial pressure(GCS 6~10)divided randomly into three groups receiving the doses of mannitol 0.25g.kg 1 (n=63) 、0.5g.kg 1 (n=65)and 1.0g.kg 1 (n=63)respectively,the various effects and probability of sequent developing acute kidney failure in these three groups have be compared.Results The morbility of acute kidney failure is markedly relative to the doses of mannitol which patients were infused.Otherwise the effect of different doses of mannitol is variant.The effect is better in the mid-dose (0.5g.kg 1 )and the high-dose(1.0g.kg 1 )mannitol groups than in the low-dose group.Conclusions The present result indicates that the benefit effect is better in the mid-dose of mannitol group and the morbidity of acute kidney failure is lower than the high-dose group.

Key concepts: Mannitol, Medicine, Intracranial pressure, Anesthesia, Kidney, Internal medicine, Organic chemistry, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of different doses of mannitol in patients with raised intracranial pressure — Research Paper | ScholarLens